Log In
Print
BCIQ
Print
Print this Print this
 

Nexagon

  Manage Alerts
Collapse Summary General Information
Company CoDa Therapeutics Inc.
DescriptionAntisense oligonucleotide that targets gap junction protein alpha 1, 43kDa (GJA1; CX43; connexin-43)
Molecular Target Gap junction protein alpha 1, 43kDa (GJA1) (CX43) (connexin-43)
Mechanism of Action 
Latest Stage of DevelopmentPhase II
IndicationDermal ulcers
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today